Fibrocell Science Inc (FCSC) - Financial and Strategic SWOT Analysis Review

1 of 5

FEATURED COMPANIES

  • Caladrius Biosciences Inc
  • Genzyme Corp
  • Neuralstem Inc
  • Vital Therapies Inc
  • MORE
Fibrocell Science Inc (FCSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Fibrocell Science Inc (Fibrocell Science) is an autologous cell and gene therapy company which discovers and develops therapies for diseases affecting the skin and connective tissue. The company’s product pipeline comprises FCX-007, a lead candidate for the treatment of recessive dystrophic epidermolysis bullosa; FCX-013 for linear scleroderma; and a research program for the treatment of arthritis and related conditions. Fibrocell Science utilizes its proprietary autologous fibroblast technology to develop personalized biologics for skin diseases. It has a manufacturing facility in Exton, Pennsylvania; and operates along with its subsidiaries in the US and Switzerland. Fibrocell Science is headquartered in Exton, Pennsylvania, the US.

Fibrocell Science Inc Key Recent Developments

Jul 02, 2018: Fibrocell Announces $4.0 Million Registered Direct Offering Priced At-the-Market
May 29, 2018: Fibrocell Announces $6.0 Million Registered Direct Offering Priced At-the-Market
May 10, 2018: Fibrocell Reports First Quarter 2018 Financial Results and Recent Highlights
Apr 18, 2018: Fibrocell Announces Review of Strategic Alternatives
Mar 19, 2018: Fibrocell Announces 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Caladrius Biosciences Inc
  • Genzyme Corp
  • Neuralstem Inc
  • Vital Therapies Inc
  • MORE
Section 1 - About the Company
  • Fibrocell Science Inc - Key Facts
  • Fibrocell Science Inc - Key Employees
  • Fibrocell Science Inc - Key Employee Biographies
  • Fibrocell Science Inc - Major Products and Services
  • Fibrocell Science Inc - History
  • Fibrocell Science Inc - Company Statement
  • Fibrocell Science Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • Fibrocell Science Inc - Business Description
  • Fibrocell Science Inc - Corporate Strategy
  • Fibrocell Science Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Fibrocell Science Inc - Strengths
  • Fibrocell Science Inc - Weaknesses
  • Fibrocell Science Inc - Opportunities
  • Fibrocell Science Inc - Threats
  • Fibrocell Science Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Fibrocell Science Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Fibrocell Science Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Fibrocell Science Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jul 02, 2018: Fibrocell Announces $4.0 Million Registered Direct Offering Priced At-the-Market
  • May 29, 2018: Fibrocell Announces $6.0 Million Registered Direct Offering Priced At-the-Market
  • May 10, 2018: Fibrocell Reports First Quarter 2018 Financial Results and Recent Highlights
  • Nov 13, 2017: Fibrocell Reports Third Quarter 2017 Financial Results and Recent Highlights
  • Aug 09, 2017: Fibrocell Reports Second Quarter 2017 Financial Results and Recent Highlights
  • May 10, 2017: Fibrocell Reports First Quarter 2017 Financial Results and Recent Operational Highlights
  • Mar 09, 2017: Fibrocell Reports 2016 Financial Results and Recent Operational Highlights
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Fibrocell Science Inc, Key Facts
  • Fibrocell Science Inc, Key Employees
  • Fibrocell Science Inc, Key Employee Biographies
  • Fibrocell Science Inc, Major Products and Services
  • Fibrocell Science Inc, History
  • Fibrocell Science Inc, Subsidiaries
  • Fibrocell Science Inc, Joint Venture
  • Fibrocell Science Inc, Key Competitors
  • Fibrocell Science Inc, Ratios based on current share price
  • Fibrocell Science Inc, Annual Ratios
  • Fibrocell Science Inc, Annual Ratios
  • Fibrocell Science Inc, Interim Ratios
  • Fibrocell Science Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Fibrocell Science Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Fibrocell Science Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Fibrocell Science Inc, Performance Chart (2013 - 2017)
  • Fibrocell Science Inc, Ratio Charts
  • Fibrocell Science Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Fibrocell Science Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Vital Therapies Inc
  • Neuralstem Inc
  • Genzyme Corp
  • Cryo-Cell International Inc
  • Caladrius Biosciences Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll